References
- SantoroNKomiJPrevalence and impact of vaginal symptoms among postmenopausal womenJ Sex Med2009682133214219493278
- SturdeeDWPanayNInternational Menopause Society Writing GroupRecommendations for the management of postmenopausal vaginal atrophyClimacteric201013650952220883118
- StikaCSAtrophic vaginitisDermatol Ther201023551452220868405
- Mac BrideMBRhodesDJShusterLTVulvovaginal atrophyMayo Clin Proc2010851879420042564
- SmithRNStuddJWRecent advances in hormone replacement therapyBr J Hosp Med199349117998088334484
- ArcherDFEfficacy and tolerability of local estrogen therapy for urogenital atrophyMenopause201017119420319602990
- BachmannGANevadunskyNSDiagnosis and treatment of atrophic vaginitisAm Fam Physician200061103090309610839558
- PastoreLMCarterRAHulkaBSWellsESelf-reported urogenital symptoms in postmenopausal women: Women’s Health InitiativeMaturitas200449429230315531125
- ParishSJNappiREKrychmanMLImpact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophyInt J Womens Health2013543744723935388
- LevineKBWilliamsREHartmannKEVulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal womenMenopause2008154 Pt 166166618698279
- NappiREKingsbergSMaamariRSimonJThe CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partnersJ Sex Med20131092232224123809691
- NappiREKokot-KierepaMWomen’s voices in the menopause: results from an international survey on vaginal atrophyMaturitas201067323323820828948
- NappiREKokot-KierepaMVaginal Health: Insights, Views and Attitudes (VIVA) – results from an international surveyClimacteric2012151364422168244
- North American Menopause SocietyThe 2012 hormone therapy position statement of: The North American Menopause SocietyMenopause201219325727122367731
- Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause SocietyMenopause2013209888902 quiz 90323985562
- Al-BaghdadiOEwiesAATopical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overviewClimacteric20091229110519117185
- MattssonLAEricssonABøgelundMMaamariRWomen’s preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophyMaturitas201374259263
- BarnerJCBranvoldAPatients’ willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultationsRes Social Adm Pharm2005117710017138467
- MinkinMJMaamariRReiterSImproved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapyInt J Womens Health2013513313923526171
- RiouxJEDevlinCGelfandMMSteinbergWMHepburnDS17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitisMenopause20007315616110810960
- ShulmanLPPortmanDJLeeWCA retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practiceJ Womens Health (Larchmt)200817456957818429700
- SucklingJLethabyAKennedyRLocal oestrogen for vaginal atrophy in postmenopausal womenCochrane Database Syst Rev20064CD00150017054136
- SimonJAKokot-KierepaMGoldsteinJNappiREVaginal health in the United States: results from the Vaginal Health: Insights, Views and Attitudes surveyMenopause201320101043104823571518